187 related articles for article (PubMed ID: 10705003)
21. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
22. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis.
Jønler M; Ritter MA; Brinkmann R; Messing EM; Rhodes PR; Bruskewitz RC
Urology; 1994 Dec; 44(6):876-82. PubMed ID: 7985316
[TBL] [Abstract][Full Text] [Related]
23. Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective.
Newton FJ; Burney S; Millar JL; Frydenberg M; Ng KT
BJU Int; 2006 Jun; 97(6):1179-83. PubMed ID: 16686708
[TBL] [Abstract][Full Text] [Related]
24. Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.
Gacci M; Livi L; Paiar F; Detti B; Litwin MS; Bartoletti R; Giubilei G; Cai T; Mariani M; Carini M
Urology; 2005 Aug; 66(2):338-43. PubMed ID: 16098363
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life after radical prostatectomy in Japanese men with localized prostate cancer.
Namiki S; Tochigi T; Kuwahara M; Ohnuma T; Ioritani N; Soma F; Shintaku I; Terai A; Nakagawa H; Satoh M; Saito S; Koinuma N; Arai Y
Int J Urol; 2003 Dec; 10(12):643-50. PubMed ID: 14633067
[TBL] [Abstract][Full Text] [Related]
26. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.
Namiki S; Tochigi T; Kuwahara M; Ioritani N; Terai A; Numata I; Satoh M; Saito S; Koinuma N; Arai Y
Int J Urol; 2004 Aug; 11(8):619-27. PubMed ID: 15285752
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden.
Thong MS; Mols F; Kil PJ; Korfage IJ; van de Poll-Franse LV
BJU Int; 2010 Mar; 105(5):652-8. PubMed ID: 19747357
[TBL] [Abstract][Full Text] [Related]
28. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life and treatment outcomes for men with prostate cancer treated by combined external-beam radiotherapy and hormone therapy.
Hashine K; Azuma K; Koizumi T; Sumiyoshi Y
Int J Clin Oncol; 2005 Feb; 10(1):45-50. PubMed ID: 15729601
[TBL] [Abstract][Full Text] [Related]
30. Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial.
Fransson P; Lund JA; Damber JE; Klepp O; Wiklund F; Fosså S; Widmark A; ;
Lancet Oncol; 2009 Apr; 10(4):370-80. PubMed ID: 19286422
[TBL] [Abstract][Full Text] [Related]
31. Erectile function after prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
[TBL] [Abstract][Full Text] [Related]
32. Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms.
Dale W; Campbell T; Ignacio L; Song P; Kopnick M; Mamo C; Ray P; Vijayakumar S
Urology; 1999 Feb; 53(2):359-66. PubMed ID: 9933055
[TBL] [Abstract][Full Text] [Related]
33. Quality of life and satisfaction with information after radical prostatectomy, radical external beam radiotherapy and postoperative radiotherapy: a long-term follow-up study.
Nicolaisen M; Müller S; Patel HR; Hanssen TA
J Clin Nurs; 2014 Dec; 23(23-24):3403-14. PubMed ID: 24890131
[TBL] [Abstract][Full Text] [Related]
34. Responsiveness of the University of California-Los Angeles Prostate Cancer Index.
Bergman J; Saigal CS; Kwan L; Litwin MS
Urology; 2010 Jun; 75(6):1418-23. PubMed ID: 19589573
[TBL] [Abstract][Full Text] [Related]
35. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166
[TBL] [Abstract][Full Text] [Related]
36. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
37. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
[TBL] [Abstract][Full Text] [Related]
38. How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.
Cooperberg MR; Koppie TM; Lubeck DP; Ye J; Grossfeld GD; Mehta SS; Carroll PR;
Urology; 2003 Jan; 61(1):190-6. PubMed ID: 12559294
[TBL] [Abstract][Full Text] [Related]
39. Defining sexual outcomes after treatment for localized prostate carcinoma.
Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
[TBL] [Abstract][Full Text] [Related]
40. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
